A Ph 1 Study of Epanova® in Healthy Chineses

Trial Identifier: D5881C00001
Sponsor: AstraZeneca
NCTID:: NCT03574142
Start Date: June 2018
Primary Completion Date: June 2018
Study Completion Date: June 2018
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Chinese Translation

Trial Locations

Country Location
China Beijing, China, 100029